Dr. Massimo Cristofanilli, MD

Claim this profile

Northwestern University

Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
10 drugs studied

Area of expertise

1Breast Cancer
Massimo Cristofanilli, MD has run 3 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 positive
HER2 negative
2Breast Cancer
Massimo Cristofanilli, MD has run 2 trials for Breast cancer. Some of their research focus areas include:
HER2 positive
Stage II
Stage III

Affiliated Hospitals

Image of trial facility.
Northwestern University
Image of trial facility.
NYP/Weill Cornell Medical Center

Clinical Trials Massimo Cristofanilli, MD is currently running

Image of trial facility.

Vaccine + Chemotherapy + Immunotherapy

for Breast Cancer

This phase II trial studies how well nab-paclitaxel, durvalumab, and tremelimumab with or without personalized synthetic long peptide vaccine (neoantigen vaccine) works in treating patients with triple negative breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as durvalumab and tremelimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. It is not yet known whether giving nab-paclitaxel, durvalumab, and tremelimumab with or without neoantigen vaccine will work better in treating patients with triple negative breast cancer.
Recruiting1 award Phase 222 criteria

More about Massimo Cristofanilli, MD

Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Massimo Cristofanilli, MD has experience with
  • Avelumab
  • Fulvestrant
  • Palbociclib
  • Paclitaxel
  • Pertuzumab
  • Trastuzumab
Breakdown of trials Massimo Cristofanilli, MD has run
Breast Cancer
Breast cancer

Other Doctors you might be interested in

Bharat B. MittalNorthwestern University
Jennifer M. LevineNYP/Weill Cornell Medical Center
Seema Jayachandran, PhDNorthwestern University

Frequently asked questions

Do I need insurance to participate in a trial?
What does Massimo Cristofanilli, MD specialize in?
Is Massimo Cristofanilli, MD currently recruiting for clinical trials?
Are there any treatments that Massimo Cristofanilli, MD has studied deeply?
What is the best way to schedule an appointment with Massimo Cristofanilli, MD?
What is the office address of Massimo Cristofanilli, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security